Trial Profile
The effects of a DPP4 inhibitor on endothelial function in diabetic patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 05 Sep 2012 New trial record